In a report published by Goldman Sachs, Hansen Natural HANS is downgraded to Neutral.
Goldman Sachs said that it is downgrading shares of HANS from Buy to Neutral in conjunction with reinstating Sara Lee (SLE) with a Buy rating. “We continue to remain constructive on the HANS story long-term, but we are taking profits given more balanced risk/reward after sizable absolute and relative outperformance over the past 6-9 months. Fundamentally, we see HANS continuing to deliver best-in-class sales growth, but we believe higher can costs could limit earnings upside in the near term. Since our upgrade on May 18, 2010 HANS shares are up 41% vs the S&P +18%. HANS share are up 38% over the past 12-months vs the S&P +16%.”
Hansen Natural closed yesterday at $56.37.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.